Online Pharmacy
   Customer Care
Online Clinic
Erectile dysfunction, weight loss and hair loss treatments, The Online Clinic
Online Clinic UK > OCUK News

OCUK News




 

Latest News

posted: Thursday, September 20, 2007 | Categories: Acomplia

Yet again we have some news on Acomplia from another part of the world and yet another clinical trial.  A study of 526 obese patients in Japan showed that Acomplia had a dramatic effect on the reduction of the dangerous visceral fat which surrounds certain organs such as the liver.  The study showed that those taking the normal 20 mg a day dose managed a reduction in visceral fat twice that of those on the placebo.

The visceral fat contains large insulin resistant fat cells which can lead to type 2 diabetes and heart disease.

In a separate announcement, Sanofi Aventis has said that it will not seek approval for Acomplia in the US for use in obese patients for around 3-4 years.  This will be a huge disappointment to many overweight Americans, many of whom contact us on a daily basis looking for Acomplia.  Unfortunately, owing to regulatory restrictions, we cannot prescribe medication to American residents.

Comments are closed.



Viagra | Cialis | Levitra | Xenical | Acomplia | Reductil | Propecia | Intrinsa | Champix | Tamiflu

Professional medical advice will be given before buying any impotence or erectile dysfunction treatments such as Viagra, Cialis and Levitra. We also offer advice on hair loss treatments and solutions such as Propecia. Please get in touch with us for weight loss treatment including Acomplia, Reductil and Xenical weight loss pills. Influenza can also be treated with Tamiflu or Relenza. If you are trying to stop smoking we can prescribe Champix. Women with hypoactive sexual desire disorder can be treated with  Intrinsa. Consultations take place online and medication is despatched to addresses in the UK for next day delivery.